-
Je něco špatně v tomto záznamu ?
Synergistic effect of the verapamil and amphotericin B against Cryptococcus neoformans
TC. Pereira, PHF. do Carmo, RT. de Menezes, HC. de Oliveira, LD. de Oliveira, JC. Junqueira, L. Scorzoni
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články
- MeSH
- amfotericin B farmakologie terapeutické užití MeSH
- antifungální látky farmakologie terapeutické užití MeSH
- Cryptococcus neoformans * MeSH
- flucytosin farmakologie terapeutické užití MeSH
- kryptokokóza * farmakoterapie mikrobiologie MeSH
- mikrobiální testy citlivosti MeSH
- Publikační typ
- časopisecké články MeSH
Cryptococcus neoformans is an encapsulated yeast that can cause cryptococcosis and cryptococcal meningitis, which conventional treatment involves antifungal drugs such as polyenes, flucytosine, azoles, and their combinations. However, the high cost, toxicity, and increase in fungi resistance to antifungal agents stimulate the search for therapeutic strategies such as drug repurposing and combination therapy. This study evaluated the activity of the antihypertensive verapamil (VEH) alone and combined with amphotericin B (AmB) against C. neoformans. VEH exhibited antifungal activity against C. neoformans with minimum inhibitory concentration and minimum fungicidal concentration of 118 μg per mL. The combination of VEH and AmB exhibited synergism, reducing at least eightfold both drugs' concentrations. Moreover, the combination decreased the size and glucuronoxylomannnan content of C. neoformans capsule. However, no difference was observed in ergosterol levels of C. neoformans after treatment with VEH and AmB in combination. Altogether, VEH in combination with AmB exhibits potential as a candidate as for the development of anti-cryptococcal drug.
Instituto Carlos Chagas Fundação Oswaldo Cruz Curitiba Brazil
Universidade de Guarulhos Programa de Pós Graduação em Enfermagem Guarulhos SP Brazil
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23020582
- 003
- CZ-PrNML
- 005
- 20231215110118.0
- 007
- ta
- 008
- 231215s2023 xr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s12223-023-01104-5 $2 doi
- 035 __
- $a (PubMed)37950840
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Pereira, Thaís C $u Department of Biosciences and Oral Diagnosis, Institute of Science and Technology, São Paulo State University (UNESP), São José dos Campos, SP, 12245-000, Brazil $1 https://orcid.org/0000000272063348
- 245 10
- $a Synergistic effect of the verapamil and amphotericin B against Cryptococcus neoformans / $c TC. Pereira, PHF. do Carmo, RT. de Menezes, HC. de Oliveira, LD. de Oliveira, JC. Junqueira, L. Scorzoni
- 520 9_
- $a Cryptococcus neoformans is an encapsulated yeast that can cause cryptococcosis and cryptococcal meningitis, which conventional treatment involves antifungal drugs such as polyenes, flucytosine, azoles, and their combinations. However, the high cost, toxicity, and increase in fungi resistance to antifungal agents stimulate the search for therapeutic strategies such as drug repurposing and combination therapy. This study evaluated the activity of the antihypertensive verapamil (VEH) alone and combined with amphotericin B (AmB) against C. neoformans. VEH exhibited antifungal activity against C. neoformans with minimum inhibitory concentration and minimum fungicidal concentration of 118 μg per mL. The combination of VEH and AmB exhibited synergism, reducing at least eightfold both drugs' concentrations. Moreover, the combination decreased the size and glucuronoxylomannnan content of C. neoformans capsule. However, no difference was observed in ergosterol levels of C. neoformans after treatment with VEH and AmB in combination. Altogether, VEH in combination with AmB exhibits potential as a candidate as for the development of anti-cryptococcal drug.
- 650 _2
- $a amfotericin B $x farmakologie $x terapeutické užití $7 D000666
- 650 _2
- $a antifungální látky $x farmakologie $x terapeutické užití $7 D000935
- 650 12
- $a Cryptococcus neoformans $7 D003455
- 650 12
- $a kryptokokóza $x farmakoterapie $x mikrobiologie $7 D003453
- 650 _2
- $a flucytosin $x farmakologie $x terapeutické užití $7 D005437
- 650 _2
- $a mikrobiální testy citlivosti $7 D008826
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a do Carmo, Paulo H F $u Department of Biosciences and Oral Diagnosis, Institute of Science and Technology, São Paulo State University (UNESP), São José dos Campos, SP, 12245-000, Brazil $1 https://orcid.org/000000033186885X
- 700 1_
- $a de Menezes, Raquel T $u Department of Biosciences and Oral Diagnosis, Institute of Science and Technology, São Paulo State University (UNESP), São José dos Campos, SP, 12245-000, Brazil $1 https://orcid.org/0000000342505528
- 700 1_
- $a de Oliveira, Haroldo C $u Instituto Carlos Chagas, Fundação Oswaldo Cruz (Fiocruz), Curitiba, Brazil $1 https://orcid.org/0000000157604209
- 700 1_
- $a de Oliveira, Luciane D $u Department of Biosciences and Oral Diagnosis, Institute of Science and Technology, São Paulo State University (UNESP), São José dos Campos, SP, 12245-000, Brazil $1 https://orcid.org/0000000199567768
- 700 1_
- $a Junqueira, Juliana C $u Department of Biosciences and Oral Diagnosis, Institute of Science and Technology, São Paulo State University (UNESP), São José dos Campos, SP, 12245-000, Brazil $1 https://orcid.org/0000000166466856
- 700 1_
- $a Scorzoni, Liliana $u Department of Biosciences and Oral Diagnosis, Institute of Science and Technology, São Paulo State University (UNESP), São José dos Campos, SP, 12245-000, Brazil. liliscorzoni@yahoo.com.br $u Universidade de Guarulhos (UNG), Programa de Pós-Graduação em Enfermagem, Guarulhos, SP, Brazil. liliscorzoni@yahoo.com.br $1 https://orcid.org/0000000201786653
- 773 0_
- $w MED00011005 $t Folia microbiologica $x 1874-9356 $g Roč. 68, č. 6 (2023), s. 999-1004
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37950840 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20231215 $b ABA008
- 991 __
- $a 20231215110112 $b ABA008
- 999 __
- $a ok $b bmc $g 2021884 $s 1207021
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 68 $c 6 $d 999-1004 $e 20231111 $i 1874-9356 $m Folia microbiologica $n Folia microbiol. (Prague) $x MED00011005
- LZP __
- $a Pubmed-20231215